Genetic analysis can improve depression therapy

The failure of SSRI antidepressants can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study. Prescribing the dose of escitalopram based on a patient's specific genetic constitution would greatly improve therapeutic outcomes.

from Latest Science News -- ScienceDaily http://ift.tt/2ATOFrR
via IFTTT
Share:

0 comments:

Post a Comment

Support